Dr. Lori Friedman Joins Drug Hunter's Distinguished Advisory Board
Drug Hunter, renowned for its role as a leading knowledge platform in drug discovery and R&D, has exciting news to share: Dr. Lori Friedman, Ph.D., is now a member of its Scientific Advisory Board (SAB). This strategic appointment is designed to enhance the organization's growing array of offerings in various drug discovery disciplines.
Expertise and Contributions of Dr. Lori Friedman
Dr. Friedman comes with an impressive background amassing over 20 years of experience in cancer research. As the Chief Scientific Officer of ORIC, she has been at the forefront of significant breakthroughs in this field. Her proficiency in cancer target discovery, drug discovery, and validation will provide invaluable support to Drug Hunter’s primary focus on empowering scientists.
Vision for Drug Discovery
The CEO and Founder of Drug Hunter, Dennis Hu, articulated excitement regarding Dr. Friedman’s appointment, emphasizing how her extraordinary expertise in biology, target selection, and clinical validation is integral as Drug Hunter broadens its impact in drug discovery biology.
Building a Strong Scientific Advisory Team
Dr. Friedman joins an esteemed group of scientists in the advisory team, including professionals such as Drs. Wendy Young, Dean Brown, Nicholas Meanwell, Daniel Erlanson, and Ken Brameld. Together, their collective experience will guide Drug Hunter in providing critical insights that help R&D leaders discover the medicines of the future.
Groundbreaking Achievements in Cancer Research
During her time at Genentech, Dr. Friedman led teams that pushed more than 20 programs into clinical trials, contributing to crucial developments in breast cancer treatments. Her innovative spirit is evident through her 28 patents and over 100 publications in peer-reviewed journals. Furthermore, her role as head of the Chemistry in Cancer Research working group showcases her leadership in the industry.
Dr. Friedman’s Commitment to Drug Hunter’s Mission
Expressing enthusiasm about her new role, Dr. Friedman stated her eagerness to contribute to the mission of empowering scientists globally. Her ambition aligns perfectly with Drug Hunter's vision of transforming scientific insights into valuable resources for drug developers.
Strengthening Industry Ties
As Drug Hunter continues to gain recognition in the pharmaceutical research and development sector, collaboration remains a cornerstone of its strategy. The organization is currently working alongside over 200 leading entities in the industry such as Eli Lilly, Biogen, and the National Institutes of Health. This cooperative environment enables Drug Hunter to deliver unparalleled insights through its innovative, searchable platform tailored for drug discovery.
About Drug Hunter
Drug Hunter is celebrated as a crucial knowledge resource for organizations striving to convert scientific knowledge into impactful medicines. By connecting the dots and synthesizing valuable lessons from a multitude of sources, Drug Hunter assists R&D scientists in navigating their challenges effectively. With a foundation built by dedicated industry scientists, over 200 prominent biotech and pharmaceutical organizations rely on Drug Hunter to enhance their research capabilities.
Frequently Asked Questions
What is Drug Hunter's primary mission?
Drug Hunter aims to empower R&D organizations by providing essential knowledge and insights that help transform scientific discoveries into effective medicines.
Who is Dr. Lori Friedman?
Dr. Lori Friedman is a seasoned expert in cancer research with over 20 years of experience, recently appointed to Drug Hunter's Scientific Advisory Board.
What contributions will Dr. Friedman make to Drug Hunter?
Dr. Friedman will provide valuable insights in biology and drug discovery, helping to enhance Drug Hunter’s services and offerings.
How many organizations collaborate with Drug Hunter?
Drug Hunter collaborates with over 200 leading organizations in the pharmaceutical R&D sector.
What resources does Drug Hunter provide to researchers?
Drug Hunter offers a unique, searchable platform that distills insights from scientific literature and patents to assist researchers in drug discovery.
